Zaloguj się

Gotowe bibliografie tematyczne / Insulin resistance / Artykuły w czasopismach

Artykuły w czasopismach na temat „Insulin resistance”

Kliknij ten link, aby zobaczyć inne rodzaje publikacji na ten temat: Insulin resistance.

Autor: Grafiati

Data publikacji: 4 czerwca 2021

Data aktualizacji: 6 lipca 2024

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Insulin resistance”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.

1

Kumar, Sinha Ritesh, i Chandra Satish. "Insulin resistance". Asian Pacific Journal of Health Sciences, Supplimentary 2014 (2014): 71–78. http://dx.doi.org/10.21276/apjhs.2014.1.1s.15.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

2

Sowers, James R., i Edward D. Frohlich. "Insulin and insulin resistance:". Medical Clinics of North America 88, nr 1 (styczeń 2004): 63–82. http://dx.doi.org/10.1016/s0025-7125(03)00128-7.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

3

Jeffery, Alison. "Insulin resistance". Nursing Standard 17, nr 32 (23.04.2003): 47–53. http://dx.doi.org/10.7748/ns2003.04.17.32.47.c3381.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

4

Tomono, Syouichi. "Insulin Resistance :". Kitakanto Medical Journal 62, nr 1 (2012): 73–74. http://dx.doi.org/10.2974/kmj.62.73.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

5

Jeffery, Alison. "Insulin resistance". Nursing Standard 17, nr 32 (23.04.2003): 47–55. http://dx.doi.org/10.7748/ns.17.32.47.s62.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

6

Park, Kyong Soo. "Insulin Resistance". Journal of the Korean Medical Association 44, nr 3 (2001): 302. http://dx.doi.org/10.5124/jkma.2001.44.3.302.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

7

Bell, David S. H. "Insulin resistance". Postgraduate Medicine 93, nr 7 (15.05.1993): 99–107. http://dx.doi.org/10.1080/00325481.1993.11701704.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

8

Carroll, P. B., i R. C. Eastman. "Insulin Resistance". Endocrinologist 1, nr 2 (kwiecień 1991): 89–97. http://dx.doi.org/10.1097/00019616-199104000-00005.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

9

DeFronzo, Ralph A. "Insulin resistance". Current Opinion in Cardiology 5, nr 5 (październik 1990): 592–98. http://dx.doi.org/10.1097/00001573-199010000-00003.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

10

Whitelaw, D. C., i S. G. Gilbey. "Insulin Resistance". Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 35, nr 5 (wrzesień 1998): 567–83. http://dx.doi.org/10.1177/000456329803500501.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

11

Sinaiko, Alan R., i Sonia Caprio. "Insulin Resistance". Journal of Pediatrics 161, nr 1 (lipiec 2012): 11–15. http://dx.doi.org/10.1016/j.jpeds.2012.01.012.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

12

VOLL, ARTUR, i JOHAN KLOSTER. "Insulin Resistance". Acta Medica Scandinavica 157, nr 3 (24.04.2009): 223–32. http://dx.doi.org/10.1111/j.0954-6820.1957.tb14430.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

13

El Ray, Ahmed, Tarik Asselah, Rami Moucari, Maged El Ghannam, Alaa A. Taha, Mohamed A. Saber, Maha Akl i in. "Insulin resistance". European Journal of Gastroenterology & Hepatology 25, nr 4 (kwiecień 2013): 421–27. http://dx.doi.org/10.1097/meg.0b013e32835c9f69.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

14

O'Doherty, R., D. Stein i J. Foley. "Insulin resistance". Diabetologia 40 (19.09.1997): S10—S15. http://dx.doi.org/10.1007/s001250051389.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

15

El-Zayadi, Abdel-Rahman. "Insulin resistance". Arab Journal of Gastroenterology 11, nr 2 (czerwiec 2010): 66–69. http://dx.doi.org/10.1016/j.ajg.2010.04.010.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

16

Altunoglu, Esma Guldal. "Insulin resistance". Istanbul Medical Journal 13, nr 3 (2012): 0. http://dx.doi.org/10.5505/1304.8503.2012.78941.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

17

Krenkel, Jessica A. "Insulin Resistance". Topics in Clinical Nutrition 17, nr 5 (grudzień 2002): 85. http://dx.doi.org/10.1097/00008486-200212000-00011.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

18

Nesbitt, Alexander. "Insulin Resistance". Journal of Advanced Nursing 44, nr 3 (20.10.2003): 327–28. http://dx.doi.org/10.1046/j.1365-2648.2003.02826_3.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

19

Wolfrum, C., E. Asilmaz, E. Luca, J. M. Friedman i M. Stoffel. "Insulin Resistance". Journal of the American Society of Nephrology 16, nr 3 (marzec 2005): 569–71. http://dx.doi.org/10.1681/01.asn.0000926692.88991.55.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

20

Chaoji, Sunanda Ashutosh. "Insulin Resistance". Vidarbha Journal of Internal Medicine 33 (6.04.2023): 27–31. http://dx.doi.org/10.25259/vjim_41_2022.

Pełny tekst źródła

Streszczenie:

The twin epidemic of ‘Diabesity’-diabetes and obesity, all over the world, both in developed and developing countries, has brought the issue of insulin resistance (IR) into new focus of research. Apart from Type 2 diabetes mellitus (DM), IR is implicated in many other clinical syndromes because of its varied metabolic and mitogenic actions. IR has been found to play important pivotal role in pathophysiology of diabesity. IR is defined as when a normal or higher insulin level fails to produce expected biological response; one predominantly affecting insulin mediated glucose disposal 20–30% reduction in the number of insulin receptors on the target cells is observed in majority of Type 2 DM patients but 1/3 of the patients may not manifest loss of number of receptors; therefore, defective post-receptor signalling is considered as the main cause of IR. Main sites of IR are liver, adipose tissue and skeletal muscles. Apart from Type 2 DM, many other clinical and genetic syndromes are associated with IR.

Style APA, Harvard, Vancouver, ISO itp.

21

O’Doherty, R., D. Stein i J. Foley. "Insulin resistance". Diabetologia 40, S3 (marzec 1997): B10—B15. http://dx.doi.org/10.1007/bf03168180.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

22

Perkins, Amanda. "Insulin resistance". Nursing Made Incredibly Easy! 22, nr 3 (10.04.2024): 5–13. http://dx.doi.org/10.1097/nme.0000000000000046.

Pełny tekst źródła

Streszczenie:

Insulin resistance is believed to be a precursor to type 2 diabetes mellitus, metabolic syndrome, and nonalcoholic fatty liver disease. Through education, nurses can understand their role in helping patients manage this condition.

Style APA, Harvard, Vancouver, ISO itp.

23

Beale, Elmus G. "Insulin Signaling and Insulin Resistance". Journal of Investigative Medicine 61, nr 1 (1.01.2013): 11–14. http://dx.doi.org/10.2310/jim.0b013e3182746f95.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

24

OʼHare, James A. "Insulin, insulin resistance, and hypertension". Current Opinion in Endocrinology and Diabetes 1, nr 1 (styczeń 1994): 147–52. http://dx.doi.org/10.1097/00060793-199400010-00027.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

25

Stumvoll, Michael, i Hans Häring. "Insulin Resistance and Insulin Sensitizers". Hormone Research in Paediatrics 55, nr 2 (2001): 3–13. http://dx.doi.org/10.1159/000063466.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

26

HOWARD, BARBARA V. "Insulin, Insulin Resistance, and Dyslipidemia". Annals of the New York Academy of Sciences 683, nr 1 Dietary Lipid (czerwiec 1993): 1–8. http://dx.doi.org/10.1111/j.1749-6632.1993.tb35687.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

27

Petersen, Max C., i Gerald I. Shulman. "Mechanisms of Insulin Action and Insulin Resistance". Physiological Reviews 98, nr 4 (1.10.2018): 2133–223. http://dx.doi.org/10.1152/physrev.00063.2017.

Pełny tekst źródła

Streszczenie:

The 1921 discovery of insulin was a Big Bang from which a vast and expanding universe of research into insulin action and resistance has issued. In the intervening century, some discoveries have matured, coalescing into solid and fertile ground for clinical application; others remain incompletely investigated and scientifically controversial. Here, we attempt to synthesize this work to guide further mechanistic investigation and to inform the development of novel therapies for type 2 diabetes (T2D). The rational development of such therapies necessitates detailed knowledge of one of the key pathophysiological processes involved in T2D: insulin resistance. Understanding insulin resistance, in turn, requires knowledge of normal insulin action. In this review, both the physiology of insulin action and the pathophysiology of insulin resistance are described, focusing on three key insulin target tissues: skeletal muscle, liver, and white adipose tissue. We aim to develop an integrated physiological perspective, placing the intricate signaling effectors that carry out the cell-autonomous response to insulin in the context of the tissue-specific functions that generate the coordinated organismal response. First, in section II, the effectors and effects of direct, cell-autonomous insulin action in muscle, liver, and white adipose tissue are reviewed, beginning at the insulin receptor and working downstream. Section III considers the critical and underappreciated role of tissue crosstalk in whole body insulin action, especially the essential interaction between adipose lipolysis and hepatic gluconeogenesis. The pathophysiology of insulin resistance is then described in section IV. Special attention is given to which signaling pathways and functions become insulin resistant in the setting of chronic overnutrition, and an alternative explanation for the phenomenon of ‟selective hepatic insulin resistanceˮ is presented. Sections V, VI, and VII critically examine the evidence for and against several putative mediators of insulin resistance. Section V reviews work linking the bioactive lipids diacylglycerol, ceramide, and acylcarnitine to insulin resistance; section VI considers the impact of nutrient stresses in the endoplasmic reticulum and mitochondria on insulin resistance; and section VII discusses non-cell autonomous factors proposed to induce insulin resistance, including inflammatory mediators, branched-chain amino acids, adipokines, and hepatokines. Finally, in section VIII, we propose an integrated model of insulin resistance that links these mediators to final common pathways of metabolite-driven gluconeogenesis and ectopic lipid accumulation.

Style APA, Harvard, Vancouver, ISO itp.

28

Chandra, Nimai Chand. "Hyperlipidimia, Hyperleptinemia and Insulin Resistance Intercorrelation with Obesity". Diabetes & Obesity International Journal 5, nr 1 (2020): 1–6. http://dx.doi.org/10.23880/doij-16000223.

Pełny tekst źródła

Streszczenie:

The present study has shown a parallel increase of triacylglycerol, cholesterol, and low density lipoprotein (LDL) along with an increase in body mass and BMI of human obese subjects. Conversely a fall in HDL concentration was observed. Plasma leptin level increased proportionately with increase of body weight as obesity advanced from obese to morbid type. A positive correlation was observed between leptin and insulin concentrations in obese subjects. A parallel increase of plasma glucose concentration was followed with decreased expression of insulin receptor, measured in adipose tissue, with the progress of obesity. The decreased insulin receptor concentration might be the reason for seen insulin resistance and increased insulin level which marked the positive correlation with associated liptin level in obese subjects.

Style APA, Harvard, Vancouver, ISO itp.

29

Zhang, Li, Tao Liu, Pei-Yong Zheng i Guang Ji. "Leptin resistance and insulin resistance". World Chinese Journal of Digestology 17, nr 15 (2009): 1534. http://dx.doi.org/10.11569/wcjd.v17.i15.1534.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

30

Sivitz, William I. "Understanding insulin resistance". Postgraduate Medicine 116, nr 1 (lipiec 2004): 41–48. http://dx.doi.org/10.3810/pgm.2004.07.1550.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

31

SARUTA, TAKAO. "Insulin resistance syndrome." Nihon Naika Gakkai Zasshi 85, nr 2 (1996): 285–91. http://dx.doi.org/10.2169/naika.85.285.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

32

Bloomgarden, Z. T. "Insulin Resistance Concepts". Diabetes Care 30, nr 5 (27.04.2007): 1320–26. http://dx.doi.org/10.2337/dc07-zb05.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

33

Fletcher, Barbara, i Cindy Lamendola. "Insulin Resistance Syndrome". Journal of Cardiovascular Nursing 19, nr 5 (wrzesień 2004): 339–45. http://dx.doi.org/10.1097/00005082-200409000-00009.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

34

Leslie, M. "Outfoxing Insulin Resistance". Science of Aging Knowledge Environment 2002, nr 36 (11.09.2002): 125nw—125. http://dx.doi.org/10.1126/sageke.2002.36.nw125.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

35

Polonsky, William. "Psychological Insulin Resistance". Diabetes Educator 33, nr 7s (lipiec 2007): 241S—244S. http://dx.doi.org/10.1177/0145721707305701.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

36

Montminy, Marc, i Seung-Hoi Koo. "Outfoxing insulin resistance?" Nature 432, nr 7020 (grudzień 2004): 958–59. http://dx.doi.org/10.1038/432958a.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

37

Funnell, Martha Mitchell. "Understanding insulin resistance". Nursing 42, nr 3 (marzec 2012): 62. http://dx.doi.org/10.1097/01.nurse.0000411421.44527.bf.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

38

Cheng, Tsung O. "Insulin Resistance Syndrome". Southern Medical Journal 91, nr 7 (lipiec 1998): 697. http://dx.doi.org/10.1097/00007611-199807000-00041.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

39

GRANBERRY, MARK C., i VIVIAN A. FONSECA. "Insulin Resistance Syndrome". Southern Medical Journal 92, nr 1 (styczeń 1999): 2–14. http://dx.doi.org/10.1097/00007611-199901000-00002.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

40

Cummings, Doyle M., Sarah Henes, Kathryn M. Kolasa, John Olsson i David Collier. "Insulin Resistance Status". Archives of Pediatrics & Adolescent Medicine 162, nr 8 (1.08.2008): 764. http://dx.doi.org/10.1001/archpedi.162.8.764.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

41

DeFronzo, Ralph A. "Introduction: Insulin Resistance". Diabetes / Metabolism Reviews 5, nr 5 (sierpień 1989): iii. http://dx.doi.org/10.1002/dmr.5610050505.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

42

Willette, Auriel A., Christine M. Burns i Barbara B. Bendlin. "Insulin Resistance andAPOEε4". JAMA Neurology 72, nr 12 (1.12.2015): 1536. http://dx.doi.org/10.1001/jamaneurol.2015.3285.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

43

Jeffery, Alison. "Prepubertal insulin resistance". Practical Diabetes 29, nr 4 (maj 2012): 130–31. http://dx.doi.org/10.1002/pdi.1676.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

44

Limoncini, A., C. Smirne, F. Corliano, C. Marconi, E. Scaglia, G. Carnevale, P. Toniutto, C. Fabris i M. Pirisi. "[725] INSULIN RESISTANCE, INSULIN SECRETION AND". Journal of Hepatology 46 (kwiecień 2007): S273. http://dx.doi.org/10.1016/s0168-8278(07)62323-x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

45

MAGSINO, CESAR H., i JUDY SPENCER. "Insulin Receptor Antibodies and Insulin Resistance". Southern Medical Journal 92, nr 7 (lipiec 1999): 717–19. http://dx.doi.org/10.1097/00007611-199907000-00013.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

46

Gallagher, Emily Jane, i Derek LeRoith. "Insulin, Insulin Resistance, Obesity, and Cancer". Current Diabetes Reports 10, nr 2 (6.03.2010): 93–100. http://dx.doi.org/10.1007/s11892-010-0101-y.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

47

Adiga, Usha, Kathyayani P i Nandith P.B. "Association of Insulin Based Insulin Resistance with Liver Biomarkers in Type 2 Diabetes mellitus". Journal of Pure and Applied Microbiology 13, nr 2 (30.06.2019): 1199–205. http://dx.doi.org/10.22207/jpam.13.2.60.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

48

Chitturi, Shivakumar, Shehan Abeygunasekera, Geoffrey C. Farrell, Jane Holmes-Walker, Jason M. Hui, Caroline Fung, Rooshdiya Karim i in. "NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome". Hepatology 35, nr 2 (luty 2002): 373–79. http://dx.doi.org/10.1053/jhep.2002.30692.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

49

Pollak, Michael N. "Insulin, insulin-like growth factors, insulin resistance, and neoplasia". American Journal of Clinical Nutrition 86, nr 3 (1.09.2007): 820S—822S. http://dx.doi.org/10.1093/ajcn/86.3.820s.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

50

Lin, Hua V., Ja-Young Kim, Alessandro Pocai, Luciano Rossetti, Lawrence Shapiro, Philipp E. Scherer i Domenico Accili. "Adiponectin Resistance Exacerbates Insulin Resistance in Insulin Receptor Transgenic/Knockout Mice". Diabetes 56, nr 8 (2.05.2007): 1969–76. http://dx.doi.org/10.2337/db07-0127.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!